Abstract:Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, has long been thought to exert its benefits by reducing cholesterol synthesis, and has been shown to significantly reduce cardiovascular events and mortality in patients with or without coronary artery disease. However, it is still unknown whether acute administration of simvastatin beneficially affects the cardiac function prior or during ischemia–reperfusion. The aim of this study is to evaluate the cardioprotective effect of acute simvastatin treatment on isolated rat hearts or isolated ischemia–reperfusion hearts. Hearts were isolated from male Sprague–Dawley rats and attached to a Langendorff apparatus. The isolated hearts with or without ischemia (15 min) and reperfusion (60 min) were perfused with different concentrations of simvastatin. The parameters of cardiac function (such as left ventricular developed pressure [LVDP], +d p /d t max, and −d p /d t max), heart rate, and coronary flow were recorded. Simvastatin (3–30 µmol/l) significantly increased LVDP, +d p /d t max, and −d p /d t max in isolated rat hearts perfused for 60 min. Heart rate was depressed by 30 µmol/l simvastatin and the coronary flow was increased by 10 and 30 µmol/l simvastatin. At a concentration of 100 µmol/l simvastatin, worsening of heart function and subsequent cardiac arrest occurred. Administration of simvastatin (3–30 µmol/l) significantly preserved cardiac function detected by LVDP, +d p /d t max, and −d p /d t max in the isolated ischemia/reperfused (15/60 min) rat hearts. Simvastatin also significantly decreased heart rate at 30 µmol/l, and increased coronary flow at 10 and 30 µmol/l in these rat hearts. However, the protective effect of simvastatin reverted to increased damage at 100 µmol/l. Only 3 µmol/l simvastatin pretreatment before 15/60 min ischemia–reperfusion altered LVDP, +d p /d t max, and −d p /d t max. Both heart rate and coronary flow were unaltered after simvastatin pretreatment. Since simvastatin at a concentration lower than 100 µmol/l exerted beneficial effects on cardiac function in isolated perfused rat hearts, it could be applied just after myocardial ischemia and reperfusion.

Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits

Simvastatin reduces myocardial infarct size via increased nitric oxide production in normocholesterolemic rabbits

Preconditioning with 3-Nitropropionic Acid Reduces Myocardial Apoptosis Induced by Ischemia-Reperfusion Injury

[Influence of fluvastatin on left ventricular remodeling after myocardial infarction in rats].

Effects of simvastatin on cardiohemodynamic responses to ischemia–reperfusion in isolated rat hearts

Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress

Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels

Short-Term Pretreatment with Atorvastatin Attenuates Left Ventricular Dysfunction, Reduces Infarct Size and Apoptosis in Acute Myocardial Infarction Rats

Direct Renin Inhibition with Aliskiren Protects Against Myocardial Ischemia/Reperfusion Injury by Activating Nitric Oxide Synthase Signaling in Spontaneously Hypertensive Rats

Single Bolus Rosuvastatin Accelerates Calcium Uptake and Attenuates Conduction Inhomogeneity in Failing Rabbit Hearts With Regional Ischemia-Reperfusion Injury

Molecular pathways involved in the cardioprotective effects of intravenous statin administration during ischemia

Atherosclerosis induced by chronic inhibition of the synthesis of nitric oxide in moderately hypercholesterolaemic rabbits is suppressed by pitavastatin

Aliskiren protects against myocardial ischaemia-reperfusion injury via an endothelial nitric oxide synthase dependent manner

Pravastatin Attenuates Atherosclerosis after Myocardial Infarction by Inhibiting Inflammatory Ly6Chigh Monocytosis in Apolipoprotein E Knockout Mice.

Rosuvastatin Preconditioning Provides Neuroprotection Against Spinal Cord Ischemia in Rats Through Modulating Nitric Oxide Synthase Expressions

Study of effect of pravastatin on apoptosis in vulnerable plaques in abdominal aorta in model rabbits

HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model

A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model

Proteomics of Ischemia and Reperfusion Myocardial Mitochondria by Administration of Simvastatin

Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration

Cardioprotective Effect of Rosuvastatin Against Isoproterenol-Induced Myocardial Infarction Injury in Rats.